North Carolina Biotechnology Center
VC Fund
Alexander, United States
North Carolina Biotechnology Center is a VC fund in Alexander focused on Biotechnology and Health Care. The North Carolina Biotechnology Center is a private, non-profit corporation funded by the N.C. General Assembly to strengthen biotechnology research, business and education statewide. The Center is not a site for laboratory research; it works to support job creation in the biotechnology industry.
- Total investments:
- 88
- Last investment:
- Lead investor:
- 84%
Last updated:
For AI agents: llms.txt
Industries North Carolina Biotechnology Center invests in
Stages North Carolina Biotechnology Center invests in
Countries North Carolina Biotechnology Center invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Grant
- $3k–$200k
- Debt Financing
- $100k–$500k
Investment Focus
Industry
- Biotechnology 38 (43%)
- Health Care 25 (28%)
- Medical 13 (15%)
- Therapeutics 12 (14%)
- Education 11 (13%)
Stage
- Debt Financing 34 (39%)
- Grant 28 (32%)
- Pre-Seed 2 (2%)
- Funding Round 2 (2%)
- Series A 1 (1%)
Country
- United States 61 (69%)
- United Kingdom 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Douglas Edgeton
CEO
|
CEO | Total investments: 0 | Find email | |
Juliana L. Blum
Entrepreneur in Residence
|
Entrepreneur in Residence | Total investments: 0 | Find email | |
John Taylor
Entrepreneur In Residence
|
Entrepreneur In Residence | Total investments: 0 | Find email | |
|
Nancy Johnston
Executive Director
|
Executive Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Atlantic Fish Company
|
Atlantic Fish Company is developing cultivated seafood via cellular agriculture and is headquartered in Raleigh-Durham, North Carolina. | $1M / Pre-Seed / Dec 01, 2023 | |
QATCH Technologies
|
QATCH Technologies company that’s developing a tool to determine the injectability and manufacturability of biopharmaceutical products. Its proprietary technology can determine if a formulation is injectable or if there will be viscosity related manufacturing problems at very early stages. | $250K / Debt Financing / May 31, 2023 | |
Phase
|
Phase provides 3D-printing medical devices for microfluidics. Phase’s proprietary platform enables PDMS (Sylgard 184) to be 3D printed at a scale and resolution that was previously unattainable. | Debt Financing / May 01, 2023 | |
Avior Bio
|
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions. Using its disruptive drug delivery technology – Speedit™ Transmucosal Film Technology – we are positioned to develop products that bring unsurpassed value in efficacy and safety. Avior has an excellent management team, a strong advisoryboard, supportive partners, dedicated scientists, and knowledgeable clinicians that position us to be successful. | $200K / Debt Financing / Feb 17, 2023 | |
Duke University
|
Duke University is a private research university in Durham, North Carolina. Home of the Blue Devils, Duke University has about 15,000 undergraduate and graduate students and a world-class faculty helping to expand the frontiers of knowledge. The university has a strong commitment to applying knowledge in service to society, both near its NorthCarolina campus and around the world. | $109.8K / Grant / Feb 17, 2023 | |
inSomaBio
|
InSoma Bio integrates biology and materials science that solve problems in tissue engineering and regenerative medicine. It offers reconstructive plastic surgeries and injectable materials. InSoma Bio was founded in 2018 by Stefan Roberts and Ashutosh Chilkoti and was headquartered in Carolina, United States. | $500K / Debt Financing / Feb 16, 2023 | |
Amalgent Therapeutics
|
Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia. The company was founded in 2020 and is headquartered in Chapel Hill, North Carolina, United States. | $250K / Debt Financing / Feb 16, 2023 | |
IngateyGen
|
IngateyGen is a biotechnology company that focuses on human nutrition with advanced allergic free peanut and lab services. | $200K / Debt Financing / Feb 16, 2023 | |
North Carolina Central University
|
When it was established in 1910, North Carolina Central University was the first public liberal arts college for African-American students. Since then, this historically black college (HBCU) has developed a reputation for excellence in academics, research, and cultural awareness. North Carolina Central University is an HBCU.North Carolina CentralUniversity offers more than 100 programs of study in nearly 30 academic departments. The school offers undergraduate and graduate degrees. Some of these programs are unique, such as the master’s degree in Jazz Studies and the bachelor’s degree in Apparel Design.NCCU also has some joint programs for graduate students. Some of these include: * Juris Doctor/Master of Library Science * Juris Doctor/Master of Business Administration * Master of Business Administration/Master of Information ScienceThe university provides several sources of financial aid, including need-based government programs and institutional scholarships. NCCU’s Alumni Association also offers scholarships. Most of the alumni scholarships are awarded to incoming freshmen, but all NNCU students are encouraged to apply.NCCU encourages diversity in its student body. Though it was originally intended only for African-American students, the college’s admissions are open to students of all races and ethnicities. | $100K / Grant / Feb 16, 2023 | |
North Carolina State University
|
North Carolina State University is an educational institution that offers graduate and undergraduate programs. The university offers academic qualifications in engineering, agriculture, life sciences, textiles and design, natural resources, and management through 106 bachelor’s degrees, 104 master’s degrees, 61 doctoral degrees, and a Doctor ofVeterinary Medicine.The University of North Carolina’s 17 campuses extend from the state’s mountains to the coast. More than 220,000 students are enrolled at 16 universities and the NC School of Science and Mathematics, the country’s first public residential high school for gifted students.North Carolina State University is one of the eight universities with a presence at the North Carolina Research Campus, where it operates a research and education organization devoted to food crops. In March 2008, the university also launched the University Sustainability Office in order to address environmental concerns on campus.North Carolina State University was founded on March 7, 1987. | $109.5K / Grant / Feb 16, 2023 | |
| See all 88 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does North Carolina Biotechnology Center invest in?
North Carolina Biotechnology Center invests primarily in Biotechnology, Health Care and Medical startups, most often at Debt Financing and Grant stage. Most of the 88 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is North Carolina Biotechnology Center's check size?
North Carolina Biotechnology Center typically joins rounds of $3k–$200k at Grant and $100k–$500k at Debt Financing. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds North Carolina Biotechnology Center participates in.
How do I contact North Carolina Biotechnology Center?
Public channels for North Carolina Biotechnology Center include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at North Carolina Biotechnology Center?
The team at North Carolina Biotechnology Center includes Douglas Edgeton (CEO), Juliana L. Blum (Entrepreneur in Residence) and John Taylor (Entrepreneur In Residence). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
